Michael Tomsicek

Michael Tomsicek

DirectoratMilestone Pharmaceuticals· In proxies 2023–2025

Michael Tomsicek sits on 1 public board.

Experience

  1. Milestone PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -79%
  2. Acrivon Therapeutics, Inc. (Nasdaq: ACRV)Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?